II. Pathophysiology
- Typically caused by antipyschotic agents, which may over-blockade Dopaminergic Receptors
 - Results in excess Cholinergic Activity due to a loss of typical Dopamine-mediated inhibition
 
III. Symptoms
- 
                          Akathisia
                          
- Motor restlessness
 - Differentiate medication side effect from mania or Anxiety Disorder
 
 - Parkinsonian Effects (longstanding Antipsychotic use)
- Shuffling gait
 - Cogwheel rigidity
 - Psychomotor retardation
 
 - 
                          Dystonias
- Involuntary major Muscle Contractions
 - Acute laryngospasm may occur
 - Spasmodic Torticollis (spasm of neck Muscles, esp. sternocleidomastoid Muscle)
 - Oculogyric Crisis (eyes fixed, staring upward or rolling back in head)
 
 
IV. Causes: Extrapyramidal Side Effects - Antipsychotics
- Haloperidol (Haldol) or Haloperidol Decanoate
 - Perphenazine (Trilafon)
 - Thiothixene HCl (Navane)
 - Fluphenazine HCl (Prolixin)
 - Trifluoperazine (Stelazine)
 - Risperidone (Risperdal)
 
V. Causes: Tardive Dyskinesia
- 
                          Antipsychotics
- Longterm use of high dose, high potency agents (e.g. Haloperidol)
 - Atypical Antipsychotics
 
 - Other medications (esp. Dopamine blockers)
- Antiparkinsonism agents (e.g. Levodopa)
 - Metoclopramide (Reglan)
 - Anticonvulsants (e.g. Phenytoin)
 - Antidepressants
- Tricyclic Antidepressants (e.g. Amitriptyline)
 - Serotonin Reuptake Inhibitors or SSRI (e.g. Fluoxetine, Sertraline)
 
 
 
VI. Adverse Effects: Reversible Extrapyramidal signs and symptoms
- Conditions responsive to anti-Parkinsons Agents
 - 
                          Neuroleptic Malignant Syndrome
                          
- Presents as Catatonia, fever, unstable Blood Pressure
 - Life-threatening; Stop Antipsychotic immediately
 
 
VII. Adverse Effects: Irreversible (Tardive Dyskinesia)
- Evaluate for these signs monthly while on Antipsychotic (see prevention as below)
 - Higher risk in elderly, cardiovascular disease risk, HIV Infection, neurologic disorders
 - Tardive Dyskinesia
- Hyperkinesia (lingual or facial)
- Blinking
 - Lip smacking
 - Sucking or chewing
 - Rolls or protrudes Tongue
 - Grimaces
 
 - Choreoathetoid extremity movement
- Clonic jerking fingers, ankles, toes
 
 - Tonic contractions of neck or back
 
 - Hyperkinesia (lingual or facial)
 
VIII. Management
- Reversible Extrapyramidal Effects
- Tolerance to affect
 - Decrease or Increase OR discontinue drug dose
 - Shift patient to an agent without Extrapyramidal Side Effects
 - Anticholinergic Agents may decrease Dystonia or Parkinsonism effects
 - Consider Beta Blockers for Akathisia
 
 - Tardive Dyskinesia
- Lower dose or discontinue medication
- Consider Clozapine as alternative Antipsychotic
 
 - Avoid adding Anticholinergic Agent (e.g. Benztropine)
- May worsen Tardive Dyskinesia (despite benefit in acute Dystonia)
 
 - Reversible Vesicular monoamine transporter 2 Inhibitors (VMAT2)
- Deutetrabenazine (Austedo)
 - Ingrezza (Valbenazine)
- Decreases Dopamine in nerve endings
 - Reduces symptoms by 50% with 6 weeks of treatment (Number Needed to Treat: 4)
 - Very expensive ($5000 per month)
 
 
 - Other symptomatic management
- Vitamin E supplementation
 - Vitamin B6 Supplementation
 - Amantadine
 
 
 - Lower dose or discontinue medication
 
IX. Prevention
- Clinicians should be alert for Extrapyramidal Side Effects (and modify therapy to reduce adverse effects)
 - Perform Abnormal Involuntary Movement Scale (AIMS) at least every 6 months while on Antipsychotic Medications
 
X. References
- (2017) Presc Lett 24(6): 36
 - Mason, Swadron and Herbert in Herbert (2019) EM:Rap C3 3(2): 8